These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 32405727)

  • 21. Mitotic recombination of chromosome arm 17q as a cause of loss of heterozygosity of NF1 in neurofibromatosis type 1-associated glomus tumors.
    Stewart DR; Pemov A; Van Loo P; Beert E; Brems H; Sciot R; Claes K; Pak E; Dutra A; Lee CC; Legius E
    Genes Chromosomes Cancer; 2012 May; 51(5):429-37. PubMed ID: 22250039
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Germline mutations in NF1 and BRCA1 in a family with neurofibromatosis type 1 and early-onset breast cancer.
    Campos B; Balmaña J; Gardenyes J; Valenzuela I; Abad O; Fàbregas P; Volpini V; Díez O
    Breast Cancer Res Treat; 2013 Jun; 139(2):597-602. PubMed ID: 23624750
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Encephalocraniocutaneous lipomatosis phenotype associated with mosaic biallelic pathogenic variants in the
    Smeijers S; Brems H; Verhaeghe A; van Paesschen W; van Loon J; Van der Auweraer S; Sciot R; Thal DR; Lagae L; Legius E; Theys T
    J Med Genet; 2024 Aug; 61(9):904-907. PubMed ID: 38825366
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pancreatic endocrine tumors are a rare manifestation of the neurofibromatosis type 1 phenotype: molecular analysis of a malignant insulinoma in a NF-1 patient.
    Perren A; Wiesli P; Schmid S; Montani M; Schmitt A; Schmid C; Moch H; Komminoth P
    Am J Surg Pathol; 2006 Aug; 30(8):1047-51. PubMed ID: 16861979
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neurofibromatosis type 1 in two siblings due to maternal germline mosaicism.
    Trevisson E; Forzan M; Salviati L; Clementi M
    Clin Genet; 2014 Apr; 85(4):386-9. PubMed ID: 23621909
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NF1 Somatic Mutation in Dystrophic Scoliosis.
    Margraf RL; VanSant-Webb C; Mao R; Viskochil DH; Carey J; Hanson H; D'Astous J; Grossmann A; Stevenson DA
    J Mol Neurosci; 2019 May; 68(1):11-18. PubMed ID: 30778836
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical presentation and genetic analyses of neurofibromatosis type 1 in independent patients with monoallelic double de novo closely spaced mutations in the NF1 gene.
    Stella A; Lastella P; Viggiano L; Bagnulo R; Resta N
    Hum Mutat; 2022 Oct; 43(10):1354-1360. PubMed ID: 35723633
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neurofibromatosis type 1-associated tumours: their somatic mutational spectrum and pathogenesis.
    Laycock-van Spyk S; Thomas N; Cooper DN; Upadhyaya M
    Hum Genomics; 2011 Oct; 5(6):623-90. PubMed ID: 22155606
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patient affected by neurofibromatosis type 1 and thyroid C-cell hyperplasia harboring pathogenic germ-line mutations in both NF1 and RET genes.
    Ercolino T; Lai R; Giachè V; Melchionda S; Carella M; Delitala A; Mannelli M; Fanciulli G
    Gene; 2014 Feb; 536(2):332-5. PubMed ID: 24361808
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mitotic recombination and compound-heterozygous mutations are predominant NF1-inactivating mechanisms in children with juvenile myelomonocytic leukemia and neurofibromatosis type 1.
    Steinemann D; Arning L; Praulich I; Stuhrmann M; Hasle H; Stary J; Schlegelberger B; Niemeyer CM; Flotho C
    Haematologica; 2010 Feb; 95(2):320-3. PubMed ID: 20015894
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Whole-exome sequencing of duodenal neuroendocrine tumors in patients with neurofibromatosis type 1.
    Noë M; Pea A; Luchini C; Felsenstein M; Barbi S; Bhaijee F; Yonescu R; Ning Y; Adsay NV; Zamboni G; Lawlor RT; Scarpa A; Offerhaus GJA; Brosens LAA; Hruban RH; Roberts NJ; Wood LD
    Mod Pathol; 2018 Oct; 31(10):1532-1538. PubMed ID: 29849115
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel and Recurring Disease-Causing NF1 Variants in Two Chinese Families with Neurofibromatosis Type 1.
    Xiao H; Yuan L; Xu H; Yang Z; Huang F; Song Z; Yang Y; Zeng C; Deng H
    J Mol Neurosci; 2018 Aug; 65(4):557-563. PubMed ID: 30046999
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biallelic inactivation of the NF1 tumour suppressor gene in juvenile myelomonocytic leukaemia: Genetic evidence of driver function and implications for diagnostic workup.
    Ramamoorthy S; Lebrecht D; Schanze D; Schanze I; Wieland I; Andrieux G; Metzger P; Hess M; Albert MH; Borkhardt A; Bresters D; Buechner J; Catala A; De Haas V; Dworzak M; Erlacher M; Hasle H; Jahnukainen K; Locatelli F; Masetti R; Stary J; Turkiewicz D; Vinci L; Wlodarski MW; Yoshimi A; Boerries M; Niemeyer CM; Zenker M; Flotho C
    Br J Haematol; 2024 Feb; 204(2):595-605. PubMed ID: 37945316
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Neurofibromatosis von Recklinghausen type 1 (NF1) - clinical picture and molecular-genetics diagnostic].
    Petrák B; Bendová Š; Lisý J; Kraus J; Zatrapa T; Glombová M; Zámečník J
    Cesk Patol; 2015; 51(1):34-40. PubMed ID: 25671360
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Allelic loss of the NF1 gene in anal malignant melanoma in a patient with neurofibromatosis type 1.
    Ishii S; Han S; Shiiba K; Mizoi T; Okabe M; Horii A; Nagura H; Matsuno S; Sasaki I
    Int J Clin Oncol; 2001 Aug; 6(4):201-4. PubMed ID: 11706558
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular genetics of neurofibromatosis type 1 (NF1).
    Shen MH; Harper PS; Upadhyaya M
    J Med Genet; 1996 Jan; 33(1):2-17. PubMed ID: 8825042
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mitotic recombination as evidence of alternative pathogenesis of gastrointestinal stromal tumours in neurofibromatosis type 1.
    Stewart DR; Corless CL; Rubin BP; Heinrich MC; Messiaen LM; Kessler LJ; Zhang PJ; Brooks DG
    J Med Genet; 2007 Jan; 44(1):e61. PubMed ID: 17209131
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Germline Neurofibromin 1 mutation enhances the anti-tumour immune response and decreases juvenile myelomonocytic leukaemia tumourigenicity.
    Wang W; Li X; Qin X; Miao Y; Zhang Y; Li S; Yao R; Yang Y; Yu L; Zhu H; Song L; Mao S; Wang X; Chen J; Feng H; Li Y
    Br J Haematol; 2023 Jul; 202(2):328-343. PubMed ID: 37144690
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exploring the somatic NF1 mutational spectrum associated with NF1 cutaneous neurofibromas.
    Thomas L; Spurlock G; Eudall C; Thomas NS; Mort M; Hamby SE; Chuzhanova N; Brems H; Legius E; Cooper DN; Upadhyaya M
    Eur J Hum Genet; 2012 Apr; 20(4):411-9. PubMed ID: 22108604
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glomus tumors in neurofibromatosis type 1: genetic, functional, and clinical evidence of a novel association.
    Brems H; Park C; Maertens O; Pemov A; Messiaen L; Upadhyaya M; Claes K; Beert E; Peeters K; Mautner V; Sloan JL; Yao L; Lee CC; Sciot R; De Smet L; Legius E; Stewart DR
    Cancer Res; 2009 Sep; 69(18):7393-401. PubMed ID: 19738042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.